What The Drug!? — Drug Design Challenge Live Stream

webinar

Thu, 13 Jun 2024, 16:00 CEST (Berlin)

Dr. Alexander Neumann, BioSolveIT, Germany

What The Drug!? — Drug Design Challenge Live Stream

Great minds do think alike. Or perhaps they don’t? What goes through the mind of a drug hunter when facing a new challenge?

In “What The Drug?!” we will dive into the thought processes, strategies, and problem-solving techniques of medicinal and computational chemists. The concept: No script. At the beginning of the session, a project is disclosed and its aims are defined. What follows is a freestyle design session where compound design decisions are commented on, providing insights into the creative and analytical processes that drive drug discovery. During the whole event, the viewers are openly invited to comment and share their input.

Anything can happen: Tasks such as “Design a nanomolar binder for target X” or “Suggest five novel scaffolds in compound Y” may arise. With the defined goal in mind, we will use BioSolveIT applications to creatively explore solutions from various angles, innovate compound design, and push the boundaries of what’s possible in drug discovery. Science coupled with ingenuity.

Let’s see how much we can achieve live in a given time frame and if the goals can be reached.

Current news

A Milestone with Our Pioneering Partner: REAL Space Crosses 100 Billion
October 14, 2026 13:51 CEST
Crossing the 100 Billion Mark REAL Space has entered the 100+ billion era. The October update brings Enamine’s Chemical Space to 113,699,103,092 virtual product molecules, opening up an even larger collection of make-on-demand chemistry for your drug discovery projects. Built from 211,806 building blocks and 161 chemical reactions, implemented as...
Read on
category
Software
Make It Double! — SeeSAR and HPSee Updates
October 14, 2026 08:00 CEST
The SeeSAR 15.1 and HPSee 2.4 Updates SeeSAR 15.1 ‘Apollo’ and HPSee 2.4 ‘Electra’ are here! The double release brings per-synthon estimates of extension result counts to Chemical Space Docking and new reference-molecule support and automatic best-spot selection to Activity Spotter. Alongside these additions, faster molecule transfers and more flexible...
Read on
Entering The Trillion Era: AMBrosia Update
October 7, 2026 13:24 CEST
More chemistry. Trillions of possibilities. AMBrosia enters its third version with more than 2.4 trillion virtual product molecules. Developed in close collaboration with Ambinter (a brand of Greenpharma), the expanded Chemical Space combines 313,777 building blocks through 54 chemical reactions, implemented as 131 technical reactions, opening up a wealth of...
Read on